CeriBell (CBLL) vs Stereotaxis (STXS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
CeriBell (CBLL) has outperformed Stereotaxis (STXS) over the past year, gaining 99.0% versus a loss of 64.5%. CeriBell is the larger company by market cap ($901.1 million vs $113.2 million), about 8.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CBLL | STXS |
|---|---|---|
| Share price | $23.48 | $1.13 |
| Market cap | $901.12M | $113.23M |
| 1-day change | -3.53% | -1.74% |
| YTD return | +7.07% | -50.87% |
| 1-year return | +98.98% | -64.47% |
| 5-year return | — | -80.94% |
| EPS (TTM) | $-1.76 | $-0.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $25.63 | $3.59 |
| 52-week low | $10.85 | $1.12 |
| Distance from 52-week high | -8.38% | -68.52% |
| Average volume | 368.08K | 818.35K |
| Shares outstanding | 38.38M | 100.20M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CeriBell is about 8.0 times larger than Stereotaxis by market value ($901.12M vs $113.23M).
- CBLL has outperformed STXS by 163.4 percentage points over the past year.
CBLL vs STXS FAQ
Which is bigger, CeriBell or Stereotaxis?
CeriBell (CBLL) is larger, with a market capitalization of $901.12M compared with $113.23M for Stereotaxis (STXS).
Which stock has performed better over the past year, CBLL or STXS?
CBLL returned +98.98% over the past 12 months, compared with -64.47% for STXS (price return, excluding dividends). Past performance does not predict future results.
Are CeriBell and Stereotaxis in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.